For example, Hansford et al. [27] identified 47 distinct pathogenic mutations in 183 GC patients meeting the clinical criteria for HDGC (25.7%); among these, pathogenic CDH1 mutations were found in 31 cases. This evidence concerns the gene CDH1 and Familial gastric cancer.